These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16261807)

  • 1. Marine pharmacology: potentialities in the treatment of infectious diseases, osteoporosis and Alzheimer's disease.
    Bourguet-Kondracki ML; Kornprobst JM
    Adv Biochem Eng Biotechnol; 2005; 97():105-31. PubMed ID: 16261807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric total synthesis of complex marine natural products.
    Hassfeld J; Kalesse M; Stellfeld T; Christmann M
    Adv Biochem Eng Biotechnol; 2005; 97():133-203. PubMed ID: 16261808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downstream processing in marine biotechnology.
    Muffler K; Ulber R
    Adv Biochem Eng Biotechnol; 2005; 97():63-103. PubMed ID: 16261806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioprocess engineering data on the cultivation of marine prokaryotes and fungi.
    Lang S; Hüners M; Verena L
    Adv Biochem Eng Biotechnol; 2005; 97():29-62. PubMed ID: 16261805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Realizing the promises of marine biotechnology.
    Luiten EE; Akkerman I; Koulman A; Kamermans P; Reith H; Barbosa MJ; Sipkema D; Wijffels RH
    Biomol Eng; 2003 Jul; 20(4-6):429-39. PubMed ID: 12919830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquaculture of "non-food organisms" for natural substance production.
    Liebezeit G
    Adv Biochem Eng Biotechnol; 2005; 97():1-28. PubMed ID: 16261804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The manzamines as an example of the unique structural classes available for the discovery and optimization of infectious disease controls based on marine natural products.
    Hamann MT
    Curr Pharm Des; 2007; 13(6):653-60. PubMed ID: 17346180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future of biotechnology-based control of disease in marine invertebrates.
    Mialhe E; Bachere E; Boulo V; Cadoret JP; Rousseau C; Cedeño V; Saraiva E; Carrera L; Calderon J; Colwell RR
    Mol Mar Biol Biotechnol; 1995 Dec; 4(4):275-83. PubMed ID: 8541979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first GCC Marine Biotechnology Symposium: Emerging Opportunities and Future Perspectives.
    Goddard S; Delghandi M; Dobretsov S; Al-Oufi H; Al-Habsi S; Burgess JG
    Mar Biotechnol (NY); 2015 Jun; 17(3):285-9. PubMed ID: 25663285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marine biotechnology for production of food ingredients.
    Rasmussen RS; Morrissey MT
    Adv Food Nutr Res; 2007; 52():237-92. PubMed ID: 17425947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marine Biotechnology: Challenges and Development Market Trends for the Enhancement of Biotic Resources in Industrial Pharmaceutical and Food Applications. A Statistical Analysis of Scientific Literature and Business Models.
    Daniotti S; Re I
    Mar Drugs; 2021 Jan; 19(2):. PubMed ID: 33530360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policy to support marine biotechnology-based solutions to global challenges.
    Ritchie RJ; Guy K; Philp JC
    Trends Biotechnol; 2013 Mar; 31(3):128-31. PubMed ID: 23394961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlocking Marine Biotechnology in the Developing World.
    Thompson CC; Kruger RH; Thompson FL
    Trends Biotechnol; 2017 Dec; 35(12):1119-1121. PubMed ID: 28890138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics meets blue biotechnology: a wealth of novelties and opportunities.
    Hartmann EM; Durighello E; Pible O; Nogales B; Beltrametti F; Bosch R; Christie-Oleza JA; Armengaud J
    Mar Genomics; 2014 Oct; 17():35-42. PubMed ID: 24780860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putting nature back into drug discovery.
    Müller-Kuhrt L
    Nat Biotechnol; 2003 Jun; 21(6):602. PubMed ID: 12776140
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel marine-derived anti-cancer agents.
    Adrian TE
    Curr Pharm Des; 2007; 13(33):3417-26. PubMed ID: 18045195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What to do in marine biotechnology?
    Tramper J; Battershill C; Brandenburg W; Burgess G; Hill R; Luiten E; Müller W; Osinga R; Rorrer G; Tredici M; Uriz M; Wright P; Wijffels R
    Biomol Eng; 2003 Jul; 20(4-6):467-71. PubMed ID: 12919833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and emerging analytical techniques for marine biotechnology.
    Burgess JG
    Curr Opin Biotechnol; 2012 Feb; 23(1):29-33. PubMed ID: 22265377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural bioactive compounds and biotechnological potential of marine bacteria.
    Debnath M; Paul AK; Bisen PS
    Curr Pharm Biotechnol; 2007 Oct; 8(5):253-60. PubMed ID: 17979723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioprospection of marine microorganisms: biotechnological applications and methods.
    Dionisi HM; Lozada M; Olivera NL
    Rev Argent Microbiol; 2012; 44(1):49-60. PubMed ID: 22610288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.